Skip to content

Study of the Effects of Probiotics Upon Infectious Episodes in Subject Aged More Than 60, During Winter.

Effects of Daily Consumption of a Probiotic on the Evolution of Infectious Episodes (ENT, Gastro-intestinal and Pulmonary), in Subject Aged 60 Years or Over, During Winter.

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00796393
Enrollment
200
Registered
2008-11-24
Start date
2008-11-30
Completion date
2010-04-30
Last updated
2011-06-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Infectious Episodes (ENT, Gastro-intestinal and Pulmonary)

Brief summary

We put forward that probiotics have an effect on infectious episodes evolution in subjects aged 60 years or over. The main objective of this research is to observe the effect of consumption of the probiotic on the average number of days with infectious episodes.

Interventions

DIETARY_SUPPLEMENTLactobacillus helveticus R0052, Bifidobacterium bifidum R0071, Bifidobacterium infantis R0033

1 pill per day for 12 weeks

DIETARY_SUPPLEMENTStarch of potato

1 pill per day for 12 weeks

Sponsors

BioFortis
CollaboratorOTHER
Institut Rosell Lallemand
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Masking
DOUBLE (Subject, Investigator)

Eligibility

Sex/Gender
ALL
Age
60 Years to 74 Years
Healthy volunteers
Yes

Inclusion criteria

* Subjects who accept not to alter their food habits

Exclusion criteria

* Food allergy * Regular consumption of probiotics * Diabetes * Respiratory deficiency * Cardiac deficiency * Cancer or chronicle disease not stabilized * Splenectomy, sickle-cell anemia * Immuno depression or immunodeficiency acquired or congenital * Immuno depressor or corticoid treatments

Design outcomes

Primary

MeasureTime frame
Number of infectious episodesDuring the study

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026